Dose tapering of biologics in Rheumatology patients with low disease activity

Your web browser is outdated and may be insecure

The RCN recommends using an updated browser such as or

CONSULTATION RESPONSE: Dose Tapering of Biologics in Rheumatology Patients With Low Disease Act

14 December 2016

Introduction
Contact

Please select:

RCN Wales has responded to the All Wales Therapeutics and Toxicology Centre consultation on dose tapering of biologics in Rheumatology patients with low disease activity

Dose tapering of biologics in Rheumatology patients with low disease activity

For further information, please contact Lisa.Turnbull@rcn.org.uk

Page last updated - 27/07/2018

天美传媒

Joining the RCN

Why should I join?

Member benefits

Employment

Pay and benefits

Support

This is nursing

Professional development

Career resources

Introducing our Library

Library member services

Locations

Become a representative

Make a difference

Have your say

Advice and support

Support services for members

Popular advice guides

News

Events

Updates from RCN leaders

About the RCN

Championing fairness for all

RCN group websites

Your Spaces

RCN Country Sites

Popular Links

RCN Regional Sites

Your web browser is outdated and may be insecure

CONSULTATION RESPONSE: Dose Tapering of Biologics in Rheumatology Patients With Low Disease Act

Your Spaces

RCN Sites

Work & Venue

Further Info

Connect with us: